CDKN2A and cancer: Thus tumor cells may enter senescence in response to conventional anti-cancer therapies such as chemotherapy [13, 14], after reactivation of p53 [15, 16] or through an Arf-p53-independent mechanism based on the loss of Skp2 [17].